Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An update on the use of immunotherapy in patients with colorectal cancer.
Nguyen M, Tipping Smith S, Lam M, Liow E, Davies A, Prenen H, Segelov E. Nguyen M, et al. Among authors: lam m. Expert Rev Gastroenterol Hepatol. 2021 Mar;15(3):291-304. doi: 10.1080/17474124.2021.1845141. Epub 2020 Nov 9. Expert Rev Gastroenterol Hepatol. 2021. PMID: 33138649 Review.
The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer.
Body A, Prenen H, Latham S, Lam M, Tipping-Smith S, Raghunath A, Segelov E. Body A, et al. Among authors: lam m. Cancer Manag Res. 2021 Mar 17;13:2567-2579. doi: 10.2147/CMAR.S262870. eCollection 2021. Cancer Manag Res. 2021. PMID: 33762848 Free PMC article. Review.
Hepatobiliary scintigraphy and liver function changes in patients with hepatocellular carcinoma treated with 166Ho-radioembolization : HBS in HCC treated with holmium-166.
Reinders MTM, Smits MJL, van Erpecum K, de Bruijne J, Bruijnen RCG, Sprengers D, de Man R, Vegt E, IJzermans JNM, Lam MGEH, Braat AJAT. Reinders MTM, et al. Among authors: lam mgeh. EJNMMI Res. 2025 Jan 9;15(1):2. doi: 10.1186/s13550-025-01196-9. EJNMMI Res. 2025. PMID: 39786516 Free PMC article.
FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004).
Spira A, Cho BC, Felip E, Garon EB, Goto K, Johnson M, Leighl N, Passaro A, Planchard D, Popat S, Yang JC, Lu X, Jiang Y, Huang J, Lam M, Kowanetz M, Wang S, Le J, Hsu JY, Zhou CC. Spira A, et al. Among authors: lam m. Lung Cancer. 2024 Dec 28;199:108066. doi: 10.1016/j.lungcan.2024.108066. Online ahead of print. Lung Cancer. 2024. PMID: 39764938 Free article. Review. No abstract available.
2,222 results